K233965 is an FDA 510(k) clearance for the UltraDrape UGPIV Barrier and Securement (34-15). Classified as Transducer, Ultrasonic, Diagnostic (product code ITX), Class II - Special Controls.
Submitted by Parker Laboratories, Inc. (Fairfield, US). The FDA issued a Cleared decision on August 15, 2024 after a review of 244 days - an extended review cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1570 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.
View all Parker Laboratories, Inc. devices